Osteogenesis imperfecta

The Lancet

Volumn 387, Issue 10028, 2016, Pages 1657-1671

  Forlino, Antonella ^a   Marini, Joan C ^b  

^a UNIVERSITY OF PAVIA   (Italy)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN; PYROPHOSPHORIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; COLLAGEN TYPE 1;

CELL DIFFERENTIATION; COLLAGEN DEFECT; COLLAGEN SYNTHESIS; CONFERENCE PAPER; DISEASE CLASSIFICATION; DISEASE COURSE; HUMAN; METABOLISM; MINERALIZATION; NONHUMAN; OSTEOBLAST; OSTEOGENESIS IMPERFECTA; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN FOLDING; PROTEIN PROCESSING; TREATMENT PLANNING; BONE DEVELOPMENT; BONE MINERALIZATION; DISEASE MANAGEMENT; GENETIC PREDISPOSITION; GENETICS; MUTATION; PATHOLOGY;

BONE DENSITY CONSERVATION AGENTS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; COLLAGEN TYPE I; DISEASE MANAGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; OSTEOBLASTS; OSTEOGENESIS; OSTEOGENESIS IMPERFECTA; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84953272204     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00728-X     Document Type: Review

References (140)

1. R Morello, TK Bertin, Y Chen et al. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta Cell 127 2006 291 304
2. AM Barnes, W Chang, R Morello et al. Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta N Engl J Med 355 2006 2757 2764
3. A Forlino, WA Cabral, AM Barnes, JC Marini New perspectives on osteogenesis imperfecta Nat Rev Endocrinol 7 2011 540 557
4. JC Marini, A Forlino, WA Cabral et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans Hum Mutat 28 2007 209 221
5. JC Marini, AR Blissett New genes in bone development: what's new in osteogenesis imperfecta J Clin Endocrinol Metab 98 2013 3095 3103
6. JP Orgel, JD San Antonio, O Antipova Molecular and structural mapping of collagen fibril interactions Connect Tissue Res 52 2011 2 17
7. DO Sillence, DL Rimoin, DM Danks Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity Birth Defects Orig Artic Ser 15 1979 113 129
8. JC Marini Osteogenesis imperfecta RM Kliegman B Stanton J St Geme N Schor RE Behrman Nelson textbook of pediatrics 19th edn. 2011 Elsevier Health Sciences Philadelphia 2437 2440
9. F Rauch, R Travers, AM Parfitt, FH Glorieux Static and dynamic bone histomorphometry in children with osteogenesis imperfecta Bone 26 2000 581 589
10. JC Marini, E Hopkins, FH Glorieux et al. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of the carboxyterminal propeptide of type I procollagen J Bone Miner Res 18 2003 237 243
11. FH Glorieux, LM Ward, F Rauch, L Lalic, PJ Roughley, R Travers Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect J Bone Miner Res 17 2002 30 38
12. FH Glorieux, F Rauch, H Plotkin et al. Type V osteogenesis imperfecta: a new form of brittle bone disease J Bone Miner Res 15 2000 1650 1658
13. Y Ishikawa, HP Bachinger A molecular ensemble in the rER for procollagen maturation Biochim Biophys Acta 1833 2013 2479 2491
14. Y Ishikawa, J Wirz, JA Vranka, K Nagata, HP Bächinger Biochemical characterization of the prolyl 3-hydroxylase 1.cartilage-associated protein.cyclophilin B complex J Biol Chem 284 2009 17641 17647
15. MA Weis, DM Hudson, L Kim, M Scott, JJ Wu, DR Eyre Location of 3-hydroxyproline residues in collagen types I, II, III, and V/XI implies a role in fibril supramolecular assembly J Biol Chem 285 2010 2580 2590
16. HP Bächinger The influence of peptidyl-prolyl cis-trans isomerase on the in vitro folding of type III collagen J Biol Chem 262 1987 17144 17148
17. JM Pace, M Wiese, AS Drenguis et al. Defective C-propeptides of the proalpha2(I) chain of type I procollagen impede molecular assembly and result in osteogenesis imperfecta J Biol Chem 283 2008 16061 16067
18. R Gioia, C Panaroni, R Besio et al. Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy Stem Cells 30 2012 1465 1476
19. MC Willing, SP Deschenes, RL Slayton, EJ Roberts Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains Am J Hum Genet 59 1996 799 809
20. SB Deak, A Nicholls, FM Pope, DJ Prockop The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen J Biol Chem 258 1983 15192 15197
21. F Malfait, S Symoens, P Coucke, L Nunes, S De Almeida, A De Paepe Total absence of the alpha2(I) chain of collagen type I causes a rare form of Ehlers-Danlos syndrome with hypermobility and propensity to cardiac valvular problems J Med Genet 43 2006 e36
22. WJ de Wet, T Pihlajaniemi, J Myers, TE Kelly, DJ Prockop Synthesis of a shortened pro-alpha 2(I) chain and decreased synthesis of pro-alpha 2(I) chains in a proband with osteogenesis imperfecta J Biol Chem 258 1983 7721 7728
23. F Malfait, S Symoens, N Goemans et al. Helical mutations in type I collagen that affect the processing of the amino-propeptide result in an osteogenesis imperfecta/Ehlers-Danlos syndrome overlap syndrome Orphanet J Rare Dis 8 2013 78
24. PH Byers, M Duvic, M Atkinson et al. Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen Am J Med Genet 72 1997 94 105
25. WA Cabral, E Makareeva, A Colige et al. Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing J Biol Chem 280 2005 19259 19269
26. A Colige, AL Sieron, SW Li et al. Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene Am J Hum Genet 65 1999 308 317
27. SW Li, M Arita, A Fertala et al. Transgenic mice with inactive alleles for procollagen N-proteinase (ADAMTS-2) develop fragile skin and male sterility Biochem J 355 2001 271 278
28. S Symoens, DJ Hulmes, JM Bourhis, PJ Coucke, A De Paepe, F Malfait Type I procollagen C-propeptide defects: study of genotype-phenotype correlation and predictive role of crystal structure Hum Mutat 35 2014 1330 1341
29. K Lindahl, AM Barnes, N Fratzl-Zelman et al. COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta Hum Mutat 32 2011 598 609
30. PV Asharani, K Keupp, O Semler et al. Attenuated BMP1 function compromises osteogenesis, leading to bone fragility in humans and zebrafish Am J Hum Genet 90 2012 661 674
31. V Martínez-Glez, M Valencia, JA Caparrós-Martín et al. Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta Hum Mutat 33 2012 343 350
32. R Pollitt, R McMahon, J Nunn et al. Mutation analysis of COL1A1 and COL1A2 in patients diagnosed with osteogenesis imperfecta type I-IV Hum Mutat 27 2006 716
33. D Palmieri, S Astigiano, O Barbieri et al. Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells Exp Cell Res 314 2008 2289 2298
34. BM Steiglitz, DR Keene, DS Greenspan PCOLCE2 encodes a functional procollagen C-proteinase enhancer (PCPE2) that is a collagen-binding protein differing in distribution of expression and post-translational modification from the previously described PCPE1 J Biol Chem 277 2002 49820 49830
35. C Moali, B Font, F Ruggiero et al. Substrate-specific modulation of a multisubstrate proteinase. C-terminal processing of fibrillar procollagens is the only BMP-1-dependent activity to be enhanced by PCPE-1 J Biol Chem 280 2005 24188 24194
36. E Kessler, K Takahara, L Biniaminov, M Brusel, DS Greenspan Bone morphogenetic protein-1: the type I procollagen C-proteinase Science 271 1996 360 362
37. DR Hopkins, S Keles, DS Greenspan The bone morphogenetic protein 1/Tolloid-like metalloproteinases Matrix Biol 26 2007 508 523
38. WN Pappano, BM Steiglitz, IC Scott, DR Keene, DS Greenspan Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases Mol Cell Biol 23 2003 4428 4438
39. JA Vranka, LY Sakai, HP Bächinger Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes J Biol Chem 279 2004 23615 23621
40. R Morello, L Tonachini, M Monticone et al. cDNA cloning, characterization and chromosome mapping of Crtap encoding the mouse cartilage associated protein Matrix Biol 18 1999 319 324
41. B Steinmann, P Bruckner, A Superti-Furga Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase J Biol Chem 266 1991 1299 1303
42. DR Eyre, M Weis, DM Hudson, JJ Wu, L Kim A novel 3-hydroxyproline (3Hyp)-rich motif marks the triple-helical C terminus of tendon type I collagen J Biol Chem 286 2011 7732 7736
43. WA Cabral, W Chang, AM Barnes et al. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta Nat Genet 39 2007 359 365
44. JC Marini, WA Cabral, AM Barnes, W Chang Components of the collagen prolyl 3-hydroxylation complex are crucial for normal bone development Cell Cycle 6 2007 1675 1681
45. WA Cabral, AM Barnes, A Adeyemo et al. A founder mutation in LEPRE1 carried by 1·5% of West Africans and 0·4% of African Americans causes lethal recessive osteogenesis imperfecta Genet Med 14 2012 543 551
46. JC Marini, WA Cabral, AM Barnes Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta Cell Tissue Res 339 2010 59 70
47. W Chang, AM Barnes, WA Cabral, JN Bodurtha, JC Marini Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex Hum Mol Genet 19 2010 223 234
48. AM Barnes, EM Carter, WA Cabral et al. Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding N Engl J Med 362 2010 521 528
49. Y Ishikawa, JA Vranka, SP Boudko et al. Mutation in cyclophilin B that causes hyperelastosis cutis in American Quarter Horse does not affect peptidylprolyl cis-trans isomerase activity but shows altered cyclophilin B-protein interactions and affects collagen folding J Biol Chem 287 2012 22253 22265
50. SM Pyott, U Schwarze, HE Christiansen et al. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes Hum Mol Genet 20 2011 1595 1609
51. WA Cabral, I Perdivara, M Weis et al. Abnormal type I collagen post-translational modification and crosslinking in a cyclophilin B KO mouse model of recessive osteogenesis imperfecta PLoS Genet 10 2014 e1004465
52. R Shaheen, AM Alazami, MJ Alshammari et al. Study of autosomal recessive osteogenesis imperfecta in Arabia reveals a novel locus defined by TMEM38B mutation J Med Genet 49 2012 630 635
53. M Volodarsky, B Markus, I Cohen et al. A deletion mutation in TMEM38B associated with autosomal recessive osteogenesis imperfecta Hum Mutat 34 2013 582 586
54. E Rubinato, A Morgan, A D'Eustacchio et al. A novel deletion mutation involving TMEM38B in a patient with autosomal recessive osteogenesis imperfecta Gene 545 2014 290 292
55. WA Cabral, E Makareeva, M Ishikawa et al. Absence of ER cation channel TMEM38B/TRIC-B causes recessive osteogenesis imperfecta by dysregulation of collagen post-translational modification Bone Abstr 3 2014 CC3
56. EC Davis, TJ Broekelmann, Y Ozawa, RP Mecham Identification of tropoelastin as a ligand for the 65-kD FK506-binding protein, FKBP65, in the secretory pathway J Cell Biol 140 1998 295 303
57. Y Alanay, H Avaygan, N Camacho et al. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta Am J Hum Genet 86 2010 551 559
58. AM Barnes, WA Cabral, M Weis et al. Absence of FKBP10 in recessive type XI osteogenesis imperfecta leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix Hum Mutat 33 2012 1589 1598
59. U Schwarze, T Cundy, SM Pyott et al. Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen Hum Mol Genet 22 2013 1 17
60. AM Barnes, G Duncan, M Weis et al. Kuskokwim syndrome, a recessive congenital contracture disorder, extends the phenotype of FKBP10 mutations Hum Mutat 34 2013 1279 1288
61. R Ha-Vinh, Y Alanay, RA Bank et al. Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2 Am J Med Genet A 131 2004 115 120
62. DR Eyre, MA Weis Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta Calcif Tissue Int 93 2013 338 347
63. T Koide, Y Nishikawa, S Asada et al. Specific recognition of the collagen triple helix by chaperone HSP47. II. The HSP47-binding structural motif in collagens and related proteins J Biol Chem 281 2006 11177 11185
64. N Nagai, M Hosokawa, S Itohara et al. Embryonic lethality of molecular chaperone hsp47 knockout mice is associated with defects in collagen biosynthesis J Cell Biol 150 2000 1499 1506
65. Y Ishida, K Nagata Autophagy eliminates a specific species of misfolded procollagen and plays a protective role in cell survival against ER stress Autophagy 5 2009 1217 1219
66. C Drögemüller, D Becker, A Brunner et al. A missense mutation in the SERPINH1 gene in Dachshunds with osteogenesis imperfecta PLoS Genet 5 2009 e1000579
67. HE Christiansen, U Schwarze, SM Pyott et al. Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta Am J Hum Genet 86 2010 389 398
68. O Semler, L Garbes, K Keupp et al. A mutation in the 5′-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus Am J Hum Genet 91 2012 349 357
69. TJ Cho, KE Lee, SK Lee et al. A single recurrent mutation in the 5′-UTR of IFITM5 causes osteogenesis imperfecta type V Am J Hum Genet 91 2012 343 348
70. EP Homan, F Rauch, I Grafe et al. Mutations in SERPINF1 cause osteogenesis imperfecta type VI J Bone Miner Res 26 2011 2798 2803
71. J Becker, O Semler, C Gilissen et al. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta Am J Hum Genet 88 2011 362 371
72. M Balasubramanian, MJ Parker, A Dalton et al. Genotype-phenotype study in type V osteogenesis imperfecta Clin Dysmorphol 22 2013 93 101
73. F Rauch, P Moffatt, M Cheung et al. Osteogenesis imperfecta type V: marked phenotypic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients J Med Genet 50 2013 21 24
74. B Kasaai, MH Gaumond, P Moffatt Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation J Biol Chem 288 2013 13278 13294
75. N Hanagata, X Li, H Morita, T Takemura, J Li, T Minowa Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice J Bone Miner Metab 29 2011 279 290
76. P Moffatt, MH Gaumond, P Salois et al. Bril: a novel bone-specific modulator of mineralization J Bone Miner Res 23 2008 1497 1508
77. N Hanagata, X Li Osteoblast-enriched membrane protein IFITM5 regulates the association of CD9 with an FKBP11-CD81-FPRP complex and stimulates expression of interferon-induced genes Biochem Biophys Res Commun 409 2011 378 384
78. F Siegrist, M Ebeling, U Certa The small interferon-induced transmembrane genes and proteins J Interferon Cytokine Res 31 2011 183 197
79. SY Cho, CS Ki, YB Sohn, SJ Kim, SH Maeng, DK Jin Osteogenesis imperfecta Type VI with severe bony deformities caused by novel compound heterozygous mutations in SERPINF1 J Korean Med Sci 28 2013 1107 1110
80. C Land, F Rauch, R Travers, FH Glorieux Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment Bone 40 2007 638 644
81. SP Becerra, V Notario The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential Nat Rev Cancer 13 2013 258 271
82. GM Quan, J Ojaimi, Y Li, V Kartsogiannis, H Zhou, PF Choong Localization of pigment epithelium-derived factor in growing mouse bone Calcif Tissue Int 76 2005 146 153
83. R Bogan, RC Riddle, Z Li et al. A mouse model for human osteogenesis imperfecta type VI J Bone Miner Res 28 2013 1531 1536
84. F Li, N Song, J Tombran-Tink, C Niyibizi Pigment epithelium derived factor enhances differentiation and mineral deposition of human mesenchymal stem cells Stem Cells 31 2013 2714 2723
85. T Akiyama, CR Dass, Y Shinoda, H Kawano, S Tanaka, PF Choong PEDF regulates osteoclasts via osteoprotegerin and RANKL Biochem Biophys Res Commun 391 2010 789 794
86. A Sekiya, H Okano-Kosugi, CM Yamazaki, T Koide Pigment epithelium-derived factor (PEDF) shares binding sites in collagen with heparin/heparan sulfate proteoglycans J Biol Chem 286 2011 26364 26374
87. CR Farber, A Reich, AM Barnes et al. A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor J Bone Miner Res 29 2014 1402 1411
88. T Tsukamoto, X Li, H Morita et al. Role of S-palmitoylation on IFITM5 for the interaction with FKBP11 in osteoblast cells PLoS One 8 2013 e75831
89. R Baron, M Kneissel WNT signaling in bone homeostasis and disease: from human mutations to treatments Nat Med 19 2013 179 192
90. E Faqeih, R Shaheen, FS Alkuraya WNT1 mutation with recessive osteogenesis imperfecta and profound neurological phenotype J Med Genet 50 2013 491 492
91. CM Laine, KS Joeng, PM Campeau et al. WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta N Engl J Med 368 2013 1809 1816
92. SM Pyott, TT Tran, DF Leistritz et al. WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta Am J Hum Genet 92 2013 590 597
93. K Keupp, F Beleggia, H Kayserili et al. Mutations in WNT1 cause different forms of bone fragility Am J Hum Genet 92 2013 565 574
94. KR Thomas, MR Capecchi Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development Nature 346 1990 847 850
95. T Murakami, A Saito, S Hino et al. Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation Nat Cell Biol 11 2009 1205 1211
96. S Symoens, F Malfait, S D'hondt et al. Deficiency for the ER-stress transducer OASIS causes severe recessive osteogenesis imperfecta in humans Orphanet J Rare Dis 8 2013 154
97. P Lapunzina, M Aglan, S Temtamy et al. Identification of a frameshift mutation in Osterix in a patient with recessive osteogenesis imperfecta Am J Hum Genet 87 2010 110 114
98. M Rohrbach, C Giunta Recessive osteogenesis imperfecta: clinical, radiological, and molecular findings Am J Med Genet C Semin Med Genet 160C 2012 175 189
99. FS van Dijk, JM Cobben, A Kariminejad et al. Osteogenesis Imperfecta: A Review with Clinical Examples Mol Syndromol 2 2011 1 20
100. A De Paepe, F Malfait The Ehlers-Danlos syndrome, a disorder with many faces Clin Genet 82 2012 1 11
101. MS Aglan, L Hosny, R El-Houssini et al. A scoring system for the assessment of clinical severity in osteogenesis imperfecta J Child Orthop 6 2012 29 35
102. RH Engelbert, CS Uiterwaal, WJ Gerver, JJ van der Net, HE Pruijs, PJ Helders Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up Arch Phys Med Rehabil 85 2004 772 778
103. E Brizola, AL Staub, TM Félix Muscle strength, joint range of motion, and gait in children and adolescents with osteogenesis imperfecta Pediatr Phys Ther 26 2014 245 252
104. K Montpetit, N Dahan-Oliel, J Ruck-Gibis, F Fassier, F Rauch, F Glorieux Activities and participation in young adults with osteogenesis imperfecta J Pediatr Rehabil Med 4 2011 13 22
105. T Sousa, V Bompadre, KK White Musculoskeletal functional outcomes in children with osteogenesis imperfecta: associations with disease severity and pamidronate therapy J Pediatr Orthop 34 2014 118 122
106. RB Singer, SA Ogston, CR Paterson Mortality in various types of osteogenesis imperfecta J Insur Med 33 2001 216 220
107. RF Widmann, FD Bitan, FJ Laplaza, SW Burke, MF DiMaio, R Schneider Spinal deformity, pulmonary compromise, and quality of life in osteogenesis imperfecta Spine 24 1999 1673 1678
108. A LoMauro, S Pochintesta, M Romei et al. Rib cage deformities alter respiratory muscle action and chest wall function in patients with severe osteogenesis imperfecta PLoS One 7 2012 e35965
109. F Thiele, CM Cohrs, A Flor et al. Cardiopulmonary dysfunction in the Osteogenesis imperfecta mouse model Aga2 and human patients are caused by bone-independent mechanisms Hum Mol Genet 21 2012 3535 3545
110. Z Radunovic, LL Wekre, LM Diep, K Steine Cardiovascular abnormalities in adults with osteogenesis imperfecta Am Heart J 161 2011 523 529
111. A Lamanna, T Fayers, S Clarke, W Parsonage Valvular and aortic diseases in osteogenesis imperfecta Heart Lung Circ 22 2013 801 810
112. K Kuurila, R Grénman, R Johansson, I Kaitila Hearing loss in children with osteogenesis imperfecta Eur J Pediatr 159 2000 515 519
113. FK Swinnen, PJ Coucke, AM De Paepe et al. Osteogenesis Imperfecta: the audiological phenotype lacks correlation with the genotype Orphanet J Rare Dis 6 2011 88
114. FK Swinnen, EM De Leenheer, PJ Coucke, CW Cremers, IJ Dhooge Stapes surgery in osteogenesis imperfecta: retrospective analysis of 34 operated ears Audiol Neurootol 17 2012 198 206
115. LR Charnas, JC Marini Communicating hydrocephalus, basilar invagination, and other neurologic features in osteogenesis imperfecta Neurology 43 1993 2603 2608
116. AH Menezes Specific entities affecting the craniocervical region: osteogenesis imperfecta and related osteochondrodysplasias: medical and surgical management of basilar impression Childs Nerv Syst 24 2008 1169 1172
117. MS Cheung, H Arponen, P Roughley et al. Cranial base abnormalities in osteogenesis imperfecta: phenotypic and genotypic determinants J Bone Miner Res 26 2011 405 413
118. K Dwan, CA Phillipi, RD Steiner, D Basel Bisphosphonate therapy for osteogenesis imperfecta Cochrane Database Syst Rev 7 2014 CD005088.
119. AK Anissipour, KW Hammerberg, A Caudill et al. Behavior of scoliosis during growth in children with osteogenesis imperfecta J Bone Joint Surg Am 96 2014 237 243
120. AD Letocha, HL Cintas, JF Troendle et al. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement J Bone Miner Res 20 2005 977 986
121. F Rauch, R Travers, H Plotkin, FH Glorieux The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta J Clin Invest 110 2002 1293 1299
122. F Rauch, S Cornibert, M Cheung, FH Glorieux Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta Bone 40 2007 821 827
123. JC Marini Should children with osteogenesis imperfecta be treated with bisphosphonates? Nat Clin Pract Endocrinol Metab 2 2006 14 15
124. CA Phillipi, T Remmington, RD Steiner Bisphosphonate therapy for osteogenesis imperfecta Cochrane Database Syst Rev 8 2008 CD005088.
125. JD Hald, E Evangelou, BL Langdahl, SH Ralston Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials J Bone Miner Res 30 2015 929 933
126. TE Uveges, KM Kozloff, JM Ty et al. Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation J Bone Miner Res 24 2009 849 859
127. DB Burr, Z Liu, MR Allen Duration-dependent effects of clinically relevant oral alendronate doses on cortical bone toughness in beagle dogs Bone 71 2015 58 62
128. N Bishop, S Adami, SF Ahmed et al. Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial Lancet 382 2013 1424 1432
129. LA Bradbury, S Barlow, F Geoghegan et al. Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists Osteoporos Int 23 2012 285 294
130. ES Orwoll, J Shapiro, S Veith et al. Evaluation of teriparatide treatment in adults with osteogenesis imperfecta J Clin Invest 124 2014 491 498
131. F Antoniazzi, E Monti, G Venturi et al. GH in combination with bisphosphonate treatment in osteogenesis imperfecta Eur J Endocrinol 163 2010 479 487
132. BP Sinder, MM Eddy, MS Ominsky, MS Caird, JC Marini, KM Kozloff Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta J Bone Miner Res 28 2013 73 80
133. I Grafe, T Yang, S Alexander et al. Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta Nat Med 20 2014 670 675
134. P Esposito, H Plotkin Surgical treatment of osteogenesis imperfecta: current concepts Curr Opin Pediatr 20 2008 52 57
135. J Ruck, N Dahan-Oliel, K Montpetit, F Rauch, F Fassier Fassier-Duval femoral rodding in children with osteogenesis imperfecta receiving bisphosphonates: functional outcomes at one year J Child Orthop 5 2011 217 224
136. K Lee, MS Park, WJ Yoo, CY Chung, IH Choi, TJ Cho Proximal migration of femoral telescopic rod in children with osteogenesis imperfecta J Pediatr Orthop 35 2014 178 184
137. Y Imajima, M Kitano, T Ueda Intramedullary fixation using Kirschner wires in children with osteogenesis imperfecta J Pediatr Orthop 35 2015 431 434
138. H Krishnan, NK Patel, JA Skinner et al. Primary and revision total hip arthroplasty in osteogenesis imperfecta Hip Int 23 2013 303 309
139. V Topouchian, G Finidori, C Glorion, JP Padovani, JC Pouliquen Posterior spinal fusion for kypho-scoliosis associated with osteogenesis imperfecta: long-term results Rev Chir Orthop Reparatrice Appar Mot 90 2004 525 532
140. GJ Janus, G Finidori, RH Engelbert, M Pouliquen, JE Pruijs Operative treatment of severe scoliosis in osteogenesis imperfecta: results of 20 patients after halo traction and posterior spondylodesis with instrumentation Eur Spine J 9 2000 486 491